Site-specific assessment of spinal radiographic progression improves detection of TNF blocker-associated disease modification in axial spondyloarthritis: longitudinal observational data from the Swiss Clinical Quality Management Registry (2023)
https://pubmed.ncbi.nlm.nih.gov/36915202/

Impact of sex on spinal radiographic progression in axial spondyloarthritis: a longitudinal Swiss cohort analysis over a period of 10 years (2023)
https://pubmed.ncbi.nlm.nih.gov/37507208/

Characterisation of patients with axial psoriatic arthritis and patients with axial spondyloarthritis and concomitant psoriasis in the SCQM registry (2023)
https://pubmed.ncbi.nlm.nih.gov/37277211/

Biological disease-modifying anti-rheumatic drugs are equally effective in psoriatic arthritis patients with low and high joint counts (2023)
https://pubmed.ncbi.nlm.nih.gov/37676822/

Differences and similarities between the EULAR/ASAS-EULAR and national recommendations for treatment of patients with psoriatic arthritis and axial spondyloarthritis across Europe (2023)
https://pubmed.ncbi.nlm.nih.gov/37601339/

Obesity Represents a Persisting Health Issue in Axial Spondyloarthritis, Particularly Affecting Socially Disadvantaged Patients (2023)
https://pubmed.ncbi.nlm.nih.gov/37453738/

Anaemia is associated with higher disease activity in axial spondyloarthritis but is not an independent predictor of spinal radiographic progression: data from the Swiss Clinical Quality Management Registry (2023)
https://pubmed.ncbi.nlm.nih.gov/37289315/

Autoantibodies against chemokines post-SARS-CoV-2 infection correlate with disease course (2023)
https://pubmed.ncbi.nlm.nih.gov/36879067/

Susceptibility to COVID-19 and Immunologic Response to Vaccination in Patients With Immune-Mediated Inflammatory Diseases (2023)
https://pubmed.ncbi.nlm.nih.gov/37539758/

Joint-level responses to tofacitinib and methotrexate: a post hoc analysis of data from ORAL Start (2023)
https://pubmed.ncbi.nlm.nih.gov/37773189/

Second and third TNF inhibitors in European patients with axial spondyloarthritis: Effectiveness and impact of the reason for switching (2023)
https://pubmed.ncbi.nlm.nih.gov/37738257/

Treatment overview of axial spondyloarthritis in 2023 (2023)
https://doi.org/10.1016/j.berh.2023.101858

Current differentiation between radiographic and non-radiographic axial spondyloarthritis is of limited benefit for prediction of important clinical outcomes: data from a large, prospective, observational cohort (2022)
https://pubmed.ncbi.nlm.nih.gov/35110365/

ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update (2022)
https://pubmed.ncbi.nlm.nih.gov/36270658/

Sacroiliac joint radiographic progression in axial spondyloarthritis is retarded by the therapeutic use of TNF inhibitors: 12-year data from the SCQM registry (2022)
https://pubmed.ncbi.nlm.nih.gov/36270744/

The impact of a csDMARD in combination with a TNF inhibitor on drug retention and clinical remission in axial spondylarthritis (2022)
https://pubmed.ncbi.nlm.nih.gov/35323903/

Predictors of ASDAS-CRP inactive disease in axial spondyloarthritis during treatment with TNF-inhibitors: Data from the EuroSpA collaboration (2022)
https://pubmed.ncbi.nlm.nih.gov/35985172/

Lessons learned from a pilot implementation of physical activity recommendations in axial spondyloarthritis exercise group therapy (2022)
https://pubmed.ncbi.nlm.nih.gov/35034652/

Prediction of histology by B-mode and PD-mode ultrasound across different joint locations and diseases (2022)
https://pubmed.ncbi.nlm.nih.gov/35820737/

Long-term persistence of antibodies after diphtheria/tetanus vaccination in immunosuppressed patients with inflammatory rheumatic diseases and healthy controls (2022)
https://pubmed.ncbi.nlm.nih.gov/35810064/

One-third of European axial spondyloarthritis patients reach pain”remission” with routine care TNF-inhibitor treatment (2022)
https://pubmed.ncbi.nlm.nih.gov/36455943/

HLA‑B27 as a predictor of efectiveness of treatment with TNF inhibitors in axial spondyloarthritis: data from the Swiss Clinical Quality Management Registry (2022)
https://pubmed.ncbi.nlm.nih.gov/36574181/

Type of mRNA COVID-19 vaccine and immunomodulatory treatment influence humoral immunogenicity in patients with inflammatory rheumatic diseases. (2022)
https://pubmed.ncbi.nlm.nih.gov/36311791/

Site-specific resolution of enthesitis in patients with axial spondyloarthritis treated with tumor necrosis factor inhibitors (2021)
https://pubmed.ncbi.nlm.nih.gov/34107999/

European bio-naïve spondyloarthritis patients initiating TNFi: Time trends in baseline characteristics, treatment retention and response (2021)
https://pubmed.ncbi.nlm.nih.gov/34940840/

Impact of the COVID-19 pandemic on the disease course of patients with inflammatory rheumatic diseases: results from the Swiss Clinical Quality Management cohort (2021)
https://pubmed.ncbi.nlm.nih.gov/32963052/

Reliability of an adapted core strength endurance test battery in individuals with axial spondylarthritis (2021)
https://pubmed.ncbi.nlm.nih.gov/32959189/

Effectiveness and treatment retention of TNF inhibitors when used as monotherapy versus comedication with csDMARDs in 15 332 patients with psoriatic arthritis. Data from the EuroSpA collaboration (2021)
https://pubmed.ncbi.nlm.nih.gov/34083206/

Impact of assessing patient-reported outcomes with mobile apps on patient–provider interaction (2021)
https://pubmed.ncbi.nlm.nih.gov/33811177/

Differences between men and women with nonradiographic axial spondyloarthritis: clinical characteristics and treatment effectiveness in a real-life prospective cohort (2020)
https://pubmed.ncbi.nlm.nih.gov/33036663/

Effectiveness of secukinumab versus an alternative TNF inhibitor in patients with axial spondyloarthritis previously exposed to TNF inhibitors in the Swiss Clinical Quality Management cohort (2020)
https://pubmed.ncbi.nlm.nih.gov/32581090/

Spinal radiographic progression in axial spondyloarthritis and the impact of classification as nonradiographic versus radiographic disease: Data from the Swiss Clinical Quality Management cohort (2020)
https://pubmed.ncbi.nlm.nih.gov/32196530/

Impact of discordance between patient’s and evaluator’s global assessment on treatment outcomes in 14 868 patients with spondyloarthritis (2020)
https://pubmed.ncbi.nlm.nih.gov/31960053/

Drug retention, inactive disease and response rates in 1860 patients with axial spondyloarthritis initiating secukinumab treatment: routine care data from 13 registries in the EuroSpA collaboration (2020)
https://pubmed.ncbi.nlm.nih.gov/32950963/

Travel patterns, risk behaviour and health problems of travellers with rheumatic diseases compared to controls: A multi-centre, observational study (2020)
https://pubmed.ncbi.nlm.nih.gov/32712263/

Ossification of the ligamentum flavum (2020)
https://pubmed.ncbi.nlm.nih.gov/31819998/

Comparison of drug survival on adalimumab, etanercept, golimumab and infliximab in patients with axial spondyloarthritis (2019)
https://pubmed.ncbi.nlm.nih.gov/31145730/

Barriers and Facilitators of Vigorous Cardiorespiratory Training in Axial Spondyloarthritis: Surveys Among Patients, Physiotherapists, and Rheumatologists (2019)
https://pubmed.ncbi.nlm.nih.gov/30004189/

Do patients with axial spondyloarthritis with radiographic sacroiliitis fulfil both the modified New York criteria and the ASAS axial spondyloarthritis criteria? Results from eight cohorts (2019)
https://pubmed.ncbi.nlm.nih.gov/31362994/

Treatment response and drug retention rates in 24 195 biologic-naïve patients with axial spondyloarthritis initiating TNFi treatment: routine care data from 12 registries in the EuroSpA collaboration (2019)
https://pubmed.ncbi.nlm.nih.gov/31431486/

The appearance of joint manifestations in the Swiss inflammatory bowel disease cohort (2019)
https://pubmed.ncbi.nlm.nih.gov/31039159/

Safety and immunogenicity of tetanus/diphtheria vaccination in patients with rheumatic diseases-a prospective multi-centre cohort study (2019)
https://pubmed.ncbi.nlm.nih.gov/30877773/

Response to Tumor Necrosis Factor Inhibition in Male and Female Patients with Ankylosing Spondylitis: Data from a Swiss Cohort (2018)
https://pubmed.ncbi.nlm.nih.gov/29449504/

TNF blockers inhibit spinal radiographic progression in ankylosing spondylitis by reducing disease activity: results from the Swiss Clinical Quality Management cohort (2018)
https://pubmed.ncbi.nlm.nih.gov/28939631/

Early undifferentiated arthritis (2018)
https://pubmed.ncbi.nlm.nih.gov/29468290/

Impact of obesity on the response to tumor necrosis factor inhibitors in axial spondyloarthritis (2017)
https://pubmed.ncbi.nlm.nih.gov/28724442/

2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis (2017)
https://pubmed.ncbi.nlm.nih.gov/28087505/

The epigenetic architecture at gene promoters determines cell type-specific LPS tolerance (2017)
https://pubmed.ncbi.nlm.nih.gov/28701277/

The Effect of Comedication With a Conventional Synthetic Disease-Modifying Antirheumatic Drug on Drug Retention and Clinical Effectiveness of Anti-Tumor Necrosis Factor Therapy in Patients With Axial Spondyloarthritis (2016)
https://pubmed.ncbi.nlm.nih.gov/27015429/

Impaired response to treatment with tumour necrosis factor α inhibitors in smokers with axial spondyloarthritis (2016)
https://pubmed.ncbi.nlm.nih.gov/25667205/

Does the reason for discontinuation of a first TNF inhibitor influence the effectiveness of a second TNF inhibitor in axial spondyloarthritis? Results from the Swiss Clinical Quality Management Cohort (2016)
https://pubmed.ncbi.nlm.nih.gov/27000865/

HLA-B27-Homodimer-Specific Antibody Modulates the Expansion of Pro-Inflammatory T-Cells in HLA-B27 Transgenic Rats (2015)
https://pubmed.ncbi.nlm.nih.gov/26125554/

Treatment with tumor necrosis factor inhibitors in axial spondyloarthritis: comparison between private rheumatology practices and academic centers in a large observational cohort (2015)
https://pubmed.ncbi.nlm.nih.gov/25362654/

Anti-tumor necrosis factor drug survival in axial spondyloarthritis is independent of the classification criteria (2015)
https://pubmed.ncbi.nlm.nih.gov/25070142/

Correlation of findings in clinical and high resolution ultrasonography examinations of the painful shoulder (2015)
https://pubmed.ncbi.nlm.nih.gov/26674725/

Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis (2015)
https://pubmed.ncbi.nlm.nih.gov/26699169/

Age at symptom onset in ankylosing spondylitis: is there a gender difference? (2014)
https://pubmed.ncbi.nlm.nih.gov/25104774/

Gender differences in axial spondyloarthritis (2014)
https://www.wjgnet.com/2220-3214/full/v4/i3/35.htm

Tumor necrosis factor α inhibition in radiographic and nonradiographic axial spondyloarthritis: results from a large observational cohort (2013)
https://pubmed.ncbi.nlm.nih.gov/23983141/

Effect of cardiovascular training on fitness and perceived disease activity in people with ankylosing spondylitis (2013)
https://pubmed.ncbi.nlm.nih.gov/23836515/

BAFF levels in patients with ankylosing spondylitis and response to anti-tumor necrosis factor treatment (2013)
https://pubmed.ncbi.nlm.nih.gov/23165181/

Smoking and spondyloarthritis. (2013)
https://pubmed.ncbi.nlm.nih.gov/23238005/

High bone turnover assessed by 18F-fluoride PET/CT in the spine and sacroiliac joints of patients with ankylosing spondylitis: comparison with inflammatory lesions detected by whole body MRI (2012)
https://pubmed.ncbi.nlm.nih.gov/22788874/

18F-fluoride PET/CT for detection of sacroiliitis in ankylosing spondylitis (2010)
https://pubmed.ncbi.nlm.nih.gov/20505935/

Public versus personal serotypes of a viral quasispecies (2003)
https://pubmed.ncbi.nlm.nih.gov/12730366/

CD4+ T-cell-epitope escape mutant virus selected in vivo (2001)
https://pubmed.ncbi.nlm.nih.gov/11433343/

Impairment of CD4(+) T cell responses during chronic virus infection prevents neutralizing antibody responses against virus escape mutants (2001)
https://pubmed.ncbi.nlm.nih.gov/11157050/

Viral persistence in vivo through selection of neutralizing antibody-escape variants (2000)
https://pubmed.ncbi.nlm.nih.gov/10688894/

Viral escape and the failure of cellular immune responses (2000)
https://pubmed.ncbi.nlm.nih.gov/11032545/